SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Hematology Consultation — Annie Oakley
| Patient | Annie Oakley |
|---|
| Date of birth | 1961-08-13 |
|---|
| Identifiers | MRN HR-NI021-SYN; SSN (made up) 000-21-4806 |
|---|
| Document date | 2026-02-17 |
|---|
| Author | Omar Salib, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Macrocytic anemia with mild leukopenia and thrombocytopenia in a woman of 64, with very low B12, raised MMA, and positive intrinsic factor antibodies. Please confirm pernicious anemia and advise on replacement, monitoring, and gastric risk. [S]
Urgency: Routine, within two weeks; B12 injections start tomorrow. [S]
Questions for the consultant:
- Do these results establish pernicious anemia, and do the low white cell and platelet counts or the raised LDH need a bone marrow examination or a hemolysis work-up?
- Which replacement schedule do you advise with these neurologic findings, and is oral B12 an option for her?
- Which tests should confirm the response, and when? Should the B12 level be repeated?
- What gastric evaluation is needed for gastric cancer and neuroendocrine tumor risk, and how often?
- What else should we watch for, such as iron deficiency, potassium, or thyroid disease?
History of Present Illness
Mrs. Oakley is seen at the request of Dr. Ellingsen one week after starting intramuscular cyanocobalamin for macrocytic anemia with low B12 and positive intrinsic factor antibodies. She has had all seven daily injections. Her tongue is less sore and her energy slightly better; the foot tingling and unsteadiness in the dark are unchanged. She has no bleeding, bruising, fevers, weight loss, or night sweats. No alcohol excess, nitrous oxide exposure, metformin, or acid suppressants. She teaches shooting classes and wants to keep doing so. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Annie Oakley was born Phoebe Ann Moses (also spelled Mosey) on August 13, 1860, in Darke County, Ohio, to Jacob Moses and Susan Wise Moses. [D]
- Her father died when she was six; two sources give pneumonia as the cause, and the Garst Museum says he died from exposure to winter weather. Her mother was left to support a large family. [D]
- She became a celebrated exhibition sharpshooter who toured with a Wild West show in the United States and Europe, and in later years she gave exhibitions and taught women to shoot. [D]
- On October 29, 1901, the show's train collided head-on with another train in North Carolina; Oakley's back was injured, and the accident ended her touring with the show. [D]
- Late in 1922 she was severely injured in an automobile accident in Florida, reported as fractures of the hip and ankle, after which she had to wear a brace on her leg; her recovery took more than a year. [D]
- Her health declined in the years after the accident, and in 1925 she moved back to Darke County, Ohio. [D]
1 later historical claim is omitted because it describes events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once daily for seven days | 1000 micrograms IM daily for one week | Intramuscular route | 2026-02-10 to 2026-02-16 | completed | S |
| Cyanocobalamin 1000 micrograms (1 mL) intramuscular injection once weekly for four weeks | 1000 micrograms IM weekly for four weeks | Intramuscular route | 2026-02-17 to 2026-03-10 | completed | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Pernicious anemia with B12 deficiency neuropathy (reduced vibration and proprioception in the feet); synthetic modern diagnosis linked to the documented 1926 cause of death | active | confirmed |
D51.0 | S — Synthetic diagnosis confirmed by B12, MMA, and intrinsic factor antibodies in the modern episode; the 1926 cause of death remains D as reported. |
| Chronic low back pain, mechanical, without radiculopathy; synthetic modern problem linked to the documented 1901 train collision and 1922 automobile accident | active | confirmed |
M54.50 | S — Synthetic chronic pain problem; the back injury and the accident are documented, its modern characteristics are synthetic. |
Physical Exam
Vital signs recorded on 2026-02-17; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Slight, pale, alert |
| Mouth | Smooth, red tongue, less inflamed |
| Lymph nodes and spleen | No lymph node enlargement; spleen not palpable |
| Neurological | Vibration absent at the toes and reduced at the ankles; proprioception reduced at the toes; Romberg positive; cognition normal |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-02-17 | Hemoglobin [Mass/volume] in Blood | 9.6 | g/dL | 11.6-15 g/dL | Low | S |
| 2026-02-17 | MCV [Entitic mean volume] in Red Blood Cells by Automated count | 110 | fL | 80-100 fL | High | S |
| 2026-02-17 | Leukocytes [#/volume] in Blood by Automated count | 4.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-02-17 | Platelets [#/volume] in Blood by Automated count | 196 | 10*3/uL | 150-400 10*3/uL | Normal | S |
| 2026-02-17 | Reticulocytes/Erythrocytes in Blood by Automated count | 6.8 | % | 0.5-2.5% | High | S |
| 2026-02-17 | Potassium [Moles/volume] in Serum or Plasma | 3.7 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
Assessment
- Pernicious anemia with B12 deficiency neuropathy (D51.0). Established. Very low B12 with raised MMA confirms deficiency, and intrinsic factor antibodies are highly specific for pernicious anemia. The mild leukopenia and thrombocytopenia, raised LDH, and raised bilirubin come from ineffective red cell production in the marrow. The reticulocyte rise to 6.8 percent at one week, with counts already climbing, confirms the diagnosis. A bone marrow examination is not needed unless the counts fail to normalize by eight weeks. The neurologic signs show dorsal column involvement, so treatment must be by injection and must not lapse. [S]
- Autoimmune gastritis and gastric risk. Pernicious anemia is the late stage of autoimmune gastritis, which raises the risk of type 1 gastric neuroendocrine tumors and gastric adenocarcinoma. She has never had an endoscopy. [S]
- Associated conditions. Autoimmune thyroid disease is common with autoimmune gastritis; her TSH is normal. Iron deficiency often appears as red cell production recovers, because absorption of dietary iron is reduced without gastric acid. [S]
Data reviewed: The presenting blood count, reticulocytes, B12, folate, MMA, intrinsic factor antibody, LDH, bilirubin, iron studies, TSH, and kidney function; today's blood count, reticulocyte count of 6.8 percent, and potassium of 3.7 mmol/L. [S]
Plan of Treatment
- Continue cyanocobalamin 1000 micrograms intramuscularly: weekly for four weeks after the daily week, then monthly for life. Oral B12 is not advised for her while neurologic signs are present, and injections should never be stopped. [S]
- If neurologic signs stop improving or symptoms return before each monthly dose, shorten the interval. [S]
- Blood count with MCV and MMA at eight weeks; do not repeat the B12 level. [S]
- Ferritin and transferrin saturation at eight weeks; if iron deficiency appears, treat it and complete the GI evaluation. [S]
- Upper endoscopy with biopsies of the gastric body and antrum in separate jars, of any polyp or nodule, and of the duodenum, with H. pylori testing. Surveillance after that by the findings: about every three years for advanced atrophy, every one to two years if neuroendocrine tumors are found. [S]
- TSH once a year. [S]
- Avoid nitrous oxide anesthesia, which inactivates B12. [S]
- Discussed with Dr. Ellingsen today; the patient agrees and has the plan in writing. [S]
- Follow-up: Hematology will see her again if the blood counts do not normalize by eight weeks or if new cytopenias appear. Primary care continues the injections and monitoring on the CMID schedule. [S]